August 2018 - Volume 38 - Issue 4
pp: 283-414

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach

Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; More

Journal of Clinical Psychopharmacology. 38(4):283-285, August 2018.



Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence

Schuster, Randi Melissa; Pachas, Gladys N.; Stoeckel, Luke; More

Journal of Clinical Psychopharmacology. 38(4):307-316, August 2018.

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial

Kelly, Deanna L.; Powell, Megan M.; Wehring, Heidi J.; More

Journal of Clinical Psychopharmacology. 38(4):317-326, August 2018.

Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database

Revet, Alexis; Montastruc, François; Raynaud, Jean-Philippe; More

Journal of Clinical Psychopharmacology. 38(4):327-335, August 2018.

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

Richards, Cynthia; Iosifescu, Dan V.; Mago, Rajnish; More

Journal of Clinical Psychopharmacology. 38(4):336-343, August 2018.



Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study

Englisch, Susanne; Jung, Hanna Sophie; Eisenacher, Sarah; More

Journal of Clinical Psychopharmacology. 38(4):357-361, August 2018.



Show: